ProSciento to Present at the Diabetes Technology Annual Meeting Read More »
ProSciento Expands Senior Management Team, Appoints Siva Mullapudi as Senior Director of CRO Services Read More »
View Our Presentation
Once-Weekly Efpeglenatide Dose-Range Effects on Glycemic Control and Body Weight in Patients With Type 2 Diabetes on Metformin or Drug Naive, Referenced to Liraglutide Read More »
Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study Read More »
Assessment of Glucose Fluxes Using Stable-Isotope Methods Read More »
